Article
Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC).
Respirology (Carlton, Vic.) - 1 Apr 2015
Kumarakulasinghe Nesaretnam Barr, van Zanwijk Nico, Soo Ross A
Abstract excerpt
Historically, patients with advanced stage non-small cell lung cancer (NSCLC) were treated with chemotherapy alone, but a therapeutic plateau has been reached. Advances in the understanding of molecular genetics have led to the recognition of multiple molecularly distinct subsets of NSCLC. This in turn has led to the development of rationally directed molecular targeted therapy, leading to improved clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.